Known targets — ChEMBL curated mechanism
ADRA2AADRA2BADRA2CADRB2AGTR1AVPR1AAVPR1BAVPR2BDKRB2CALCRCHRNA3CHRNB4ESR1ESR2GHSRGNRHRGSC1HSPA8MALT1MC1RMC4RNOS1NOS2NOS3OPRK1OXTRRAMP1RAMP2RAMP3SCN5ASSTR1SSTR2SSTR3SSTR4SSTR5dacAdacBdacCfolPftsImrcAmrcBmrdArplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Acetic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOB | P27338 | 15/20 | 0.46 |
| ▸ | PPARD | Q03181 | 1/20 | 0.44 |
| ▸ | MAOA | P21397 | 1/20 | 0.44 |
| ▸ | ALB | P02768 | 1/20 | 0.42 |
| ▸ | LTB4R | Q15722 | 2/20 | 0.41 |
| ▸ | LTB4R2 | Q9NPC1 | 1/20 | 0.41 |
| ▸ | BCHE | P06276 | 1/20 | 0.41 |
| ▸ | ACHE | P22303 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7711188 | 0.97 | MAOB (0.48) | MAOBPPARDMAOAALBLTB4R | |
| Hydrochloric Acid SCHEMBL8995085 | 0.96 | MAOB (0.47) | MAOBPPARDMAOAALBLTB4R | |
| SCHEMBL9427614 | 0.87 | MAOB (0.48) | MAOBPPARDMAOAALBLTB4R | |
| SCHEMBL8995037 | 0.86 | THRB (0.43) | MAOBMAOAALBLTB4RLTB4R2 | |
| Hydrochloric Acid SCHEMBL8995056 | 0.86 | LTB4R (0.44) | MAOBMAOAALBLTB4RLTB4R2 | |
| SCHEMBL8593213 | 0.85 | LTB4R (0.42) | MAOBPPARDALBLTB4RLTB4R2 | |
| Hydrochloric Acid SCHEMBL8995059 | 0.85 | THRB (0.43) | MAOBMAOAALBLTB4RLTB4R2 | |
| Hydrochloric Acid SCHEMBL9141519 | 0.85 | MAOB (0.43) | MAOBPPARDMAOAALBBCHE | |
| Hydrochloric Acid SCHEMBL8592032 | 0.84 | LTB4R (0.42) | MAOBPPARDALBLTB4RLTB4R2 | |
| Hydrochloric Acid SCHEMBL8994966 | 0.84 | LTB4R (0.49) | MAOBPPARDMAOALTB4RLTB4R2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6380259-B2 | SUCH AS CHRONIC BRONCHITIS, COMPOUNDS SUCH AS 4-(5-(4-(AMINOIMINOMETHYL)PHENOXY)PENTOXY)-2-HYDROXY-N,N-BIS-( 1-METHYLETHYL)BENZAMIDE (Z)-2-BUTENEDIOATE | NOVARTIS AG (CH) | 2002-04-30 | — | — | US | disclosed |
| US-20010000341-A1 | Use of substituted amidino compounds in the treatment of chronic obstructive pulmonary disease | NOVARTIS AG (CH) | 2001-04-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20010000341-A1 | Use of substituted amidino compounds in the treatment of chronic obstructive pulmonary disease | HRH4, CBR1, ACOX1 | MAOB 1029/4885PPARD 221/4885MAOA 1006/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.